Ramosetron Versus Ondansetron in Combination With Aprepitant and Dexamethasone for the Prevention of Highly Emetogenic Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Randomized Phase III Trial, KCSG PC10-21.
Kim HJ, Shin SW, Song EK, Lee NR, Kim JS, Ahn JS, Yun HJ, Cho YH, Park KU, Kim SY, Jang JS, Kim SW, Lee HW, Lee SR, Kim YS, Lee SN, Ko YH, Kim HJ, Kang JH.
Kim HJ, et al. Among authors: kim sw, kim sy, kim js, kim ys.
Oncologist. 2015 Dec;20(12):1440-7. doi: 10.1634/theoncologist.2015-0128. Epub 2015 Oct 28.
Oncologist. 2015.
PMID: 26512046
Free PMC article.
Clinical Trial.